Replies to post #155747 on Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Yes, correct, according to the February 10, 2016 PR they will be doing a Phase 2 trial at 3 doses per week, but in a later release (that I can't seem to find from the patio) I believe it would be 3 times a week in a 1b/2 trial which means a dose escalation element in a POC and optimization protocol.

The Kevetrin Ovarian 1B is 3 doses per week. Based on what's seen after 1B, they could do even 4 or 5...etc doses per week to start Phase 2...correct?

Possible for them to run a POC Ovarian Phase 2 using the oral formulation while they are in Ovarian Phase 2 using the IV delivery?